|
|
ScienceDaily (July 5, 2009) — In a discovery that rebuffs conventional scientific thinking, researchers at Georgetown University Medical Center (GUMC) have discovered a novel way to block the activity of the fusion protein responsible for Ewing's sarcoma, a rare cancer found in children and young adults. In the paper published online July 5 in Nature Medicine, they report discovering and successfully testing a small molecule that keeps the fusion protein from sticking to another protein that is critical for tumor formation. The researchers say this interaction is unique – and is especially surprising since the Ewing's sarcoma fusion protein is extremely flexible, which allows it to change shape constantly. "Most targeted small molecule cancer drugs inhibit the intrinsic activity of a single protein, but our agent stops two... [read full story]
http://www.companiesandmarkets.com/Summary-Market-Report/biotechnology-reagents-a-global-market-perspective-169363.asp ""Reagents used in biotechnology are complex chemical compounds used in a range of biotech related areas...
Oerlikon Barmag a pioneer in the field of POY technology recently installed the first of its kind large scale POY direct spinning which incorporates WINGS technology, in a textile unit located in the Union Territory of Daman....
Canadian banking giant Scotiabank has announced that they’ll move forward with mobile banking services in the spring of next year. With almost 13 million customers worldwide, me thinks a lot of folks are going to love the new...
Adelaide, Australia, Nov 25, 2009 - (ABN Newswire) - Beach Petroleum Limited (ASX:BPT)(PINK:BEPTF) is proposing to change its name to more accurately include its emerging role in low-emissions energy technologies and solutions,...
